Ending the R&D Crisis in Public Health
Promoting pro-poor medical innovation
- 326.22 KB
Published: 13 November 2008
Diseases that disproportionately affect the developing world cause immense suffering and ill health.
- Medical innovation has the potential to deliver new medicines, vaccines, and diagnostics to overcome these diseases, yet few treatments have emerged.
- Current efforts to resolve the crisis are inadequate: financing for research and development (R&D) is insufficient, uncoordinated, and mostly tied to the system of intellectual property rights.
- Delivering appropriate medicines and vaccines requires reforms to the existing R&D system and a willingness to invest in promising new approaches.
- Ultimately, it is a combined responsibility of all countries to find ways to ensure global R&D is organized to improve human health; inability to pay should not disenfranchise a large majority of the world’s population from access to effective healthcare.